Oaktree Acquisition Corp. III Life Sciences OACC
NASDAQ OACC
$10.82 +0.07 (+0.65%)
At close: Aug 20, 2026 · 4:00 PM EDT

Oaktree Acquisition Corp. III Life Sciences (OACC) EBITDA (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences' (OACC) quarterly EBITDA came in at -$456538.0 in Q1 2026, down 2.64% YoY from -$468910.1 in Q1 2025, and down 78.69% on a QoQ basis from -$255496.0 in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) EBITDA (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences (OACC) has 2 years of EBITDA data on file, last reported at -$456538.0 in Q1 2026.

  • Quarterly EBITDA fell 2.64% year-over-year to -$456538.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 million (changed N/A YoY) and the FY2025 annual result came in at -$1.2 million, down 239.87% from the prior year.
  • EBITDA eased to -$456538.0 in Q1 2026, from -$255496.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$225579.0 in Q3 2025 to a low of -$456538.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - -162,277.00
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - -194,528.00
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - -112,227.00
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - -174,182.00
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - -1.47 Mn
6 Aldel Financial 397.49 Mn 397.49 Mn - -115,742.00
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - -96,300.00
8 Gores Holdings X 385.06 Mn 384.87 Mn - -1.35 Mn
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - -
10 Oaktree Acquisition Corp. III Life Sciences 206.39 Mn 206.39 Mn - -261,958.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -261,958.00
Mar 31, 2026 -456,538.00
Dec 31, 2025 -255,496.00
Sep 30, 2025 -225,579.00
Jun 30, 2025 -269,810.00
Mar 31, 2025 -444,802.00